Skip to content

Drug interactions

Erdafitinib + Paliperidone

Severity: Moderate

Erdafitinib and Paliperidone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib may inhibit P-glycoprotein, and paliperidone is a P-gp substrate, so paliperidone exposure may increase. This could raise dose-related adverse effects such as QT prolongation and extrapyramidal symptoms.

What this interaction means in plain words

Erdafitinib and Paliperidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Paliperidone belongs to Central Nervous System.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein efflux of paliperidone by erdafitinib.

What to do

Separate paliperidone and erdafitinib dosing by at least 6 hours where an oral paliperidone formulation is used. Monitor for paliperidone adverse effects.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Paliperidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Paliperidone?

MediHelp rates the interaction as moderate. Erdafitinib and Paliperidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib may inhibit P-glycoprotein, and paliperidone is a P-gp substrate, so paliperidone exposure may increase. This could raise dose-related adverse effects such as QT prolongation and extrapyramidal symptoms.

How serious is the interaction between Erdafitinib and Paliperidone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Separate paliperidone and erdafitinib dosing by at least 6 hours where an oral paliperidone formulation is used. Monitor for paliperidone adverse effects.

What other medicines interact with Paliperidone?

MediHelp also lists interactions of Paliperidone with, for example, Ibutilide, Pimozide, Vandetanib. The full list is on the Paliperidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in